Yes you are correct...cash is undoubtedly king, and the one common denominator of everything is economics.
I guess I was just feeling the weltschmerz of not being recognized/acknowledged/mentioned as even an existing let alone promising treatment in the mainstream article (Newsweek). It sure looked like exclusion?
The Neurology Review article suited me much better. The insiders in this field have a better grasp of our compound's potential.
Still think you hit it when you said we will be recognized by a BP for what we have, when the science pans out. Don't think we would go it alone.
My next best scenario is a deus ex machina of the "reverse Zika virus damage" variety, which could come out of nowhere and literally swoop us up to high ground. It's not impossible, as you may know.
And I don't look to this scenario out of desperation, rather out of optimism. There's more than one way to skin a cat, and I think the Dr has an innovative, often surprising, way of looking at things. In any case, here's hoping for the best for AVXL and all holding.
News 
Market Data 
Discover 
